Invention Grant
- Patent Title: Ophthalmic formulations of cetirizine and methods of use
-
Application No.: US16001679Application Date: 2018-06-06
-
Publication No.: US10675279B2Publication Date: 2020-06-09
- Inventor: Mark Barry Abelson , Matthew J. Chapin , Paul Gomes , George Minno , Jackie Nice
- Applicant: Nicox Ophthalmics, Inc
- Applicant Address: US TX Fort Worth
- Assignee: NICOX OPTHALMICS, INC.
- Current Assignee: NICOX OPTHALMICS, INC.
- Current Assignee Address: US TX Fort Worth
- Agency: Arent Fox, LLP
- Main IPC: A61K31/495
- IPC: A61K31/495 ; A61K31/569 ; A61K31/4174 ; A61K31/4965 ; A61K31/56 ; A61K47/02 ; A61K47/10 ; A61K47/18 ; A61K47/26 ; A61K47/38 ; A61K9/00 ; A61K9/08
Abstract:
The present invention provides stable topical formulations of cetirizine that provide a comfortable formulation when instilled in the eye and is effective in the treatment of allergic conjunctivitis and/or allergic conjunctivitis. The invention further provides methods of treating allergic conjunctivitis and/or allergic rhinoconjunctivitis in a subject in need of such treatment by topical application of the cetirizine formulations of the invention directly to the eye.
Public/Granted literature
- US20180280383A1 OPHTHALMIC FORMULATIONS OF CETIRIZINE AND METHODS OF USE Public/Granted day:2018-10-04
Information query
